Other limits may apply at checkout
In some circumstances, a conditional marketing authorisation may be granted where the benefitrisk balance is positive but further confirmatory data are still awaited
In the early weeks of treatment, more frequent clinical review (for example, at four to twelve weeks) may be appropriate to assess tolerability, monitor for adverse effects, and optimise any concurrent diabetes medications
Currently, Wegovy is only approved for weight loss, cardiovascular risk reduction, and fatty liver disease
Official Hydrafacial Before & After After Before Bouncier, More Rested Skin Improved fullness, radiance, and smoothness in skin that was starting to look a little tired
Highest nausea rate among comparable medications (44%)